3rd Quarter - Report
ALSTON & BIRD LLP for CELGENE CORPORATION
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to prescription drugs in health care bills; Issues related to coding of products; orphan drug and rare disease bill; Family Cord Blood Banking Act; Cancer Drug Coverage Parity Act of 2013 (H.R. 1801); Patients' Access to Treatment Act of 2013 (H.R. 460); MODDERN Cures Act of 2013 (H.R. 3116); Veterans access legislation (H.R. 3230/H.R. 4810); The America Invents Act; H.R. 5657, the FAST Generics Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER L BUTLER | — |
| ROBERT J DOLE | — |
| JOYCE E GRESKO | — |
| ELINOR HILLER | — |
| PETER M KAZON New | — |
| RUDY MISSMAR | — |
| MICHAEL PARK | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| MARC SCHEINESON | — |
| THOMAS A SCULLY New | Associate Dir. for Legislative Affairs, OMB |
| REGINA MARIA SHERICK | — |
| ROBERT SIGGINS | — |
| CAROLYN E SMITH | — |
| TIMOTHY P TRYSLA | — |
| MARILYN K YAGER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.